Clinical trial
Chemotherapy in Treating Children With Relapsed Acute Leukemia, Acute Myeloid…
NCT00003735 · Children's Oncology Group, Other · Completed
Key facts
| NCT number | NCT00003735 |
|---|---|
| Title | Chemotherapy in Treating Children With Relapsed Acute Leukemia, Acute Myeloid Leukemia, or Blastic Phase Chronic Myelogenous Leukemia |
| Official title | A Phase II Study of Oral Topotecan in Children With Relapsed Acute Leukemia |
| Lead sponsor | Children's Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Leukemia |
| Intervention type | Drug |
| Interventions | topotecan hydrochloride |
| Enrollment | 11 |
| Start date | Dec 1, 1998 |
| Primary completion | Nov 1, 2002 |
| Completion | Sep 1, 2006 |
| First posted | Apr 23, 2004 |
| Last update posted | Jul 24, 2014 |
| Countries | Australia, Canada, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: